These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17984354)

  • 1. Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters.
    Mateo RI; Xiao SY; Travassos da Rosa AP; Lei H; Guzman H; Lu L; Tesh RB
    Am J Trop Med Hyg; 2007 Nov; 77(5):919-24. PubMed ID: 17984354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity.
    Monath TP; Lee CK; Julander JG; Brown A; Beasley DW; Watts DM; Hayman E; Guertin P; Makowiecki J; Crowell J; Levesque P; Bowick GC; Morin M; Fowler E; Trent DW
    Vaccine; 2010 May; 28(22):3827-40. PubMed ID: 20347059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.
    McArthur MA; Xiao SY; Barrett AD
    Virus Res; 2005 Jun; 110(1-2):65-71. PubMed ID: 15845256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever virus isolated from a fatal post vaccination event: an experimental comparative study with the 17DD vaccine strain in the Syrian hamster (Mesocricetus auratus).
    Rodrigues SG; da Rosa AP; Galler R; Barros VL; Vieira Cde M; da Rosa JF; Azevedo Rdo S; Nunes MR; da Rosa ES; Vasconcelos PF
    Rev Soc Bras Med Trop; 2004; 37 Suppl 2():69-74. PubMed ID: 15586900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppression on West Nile virus infection in hamsters.
    Mateo R; Xiao SY; Guzman H; Lei H; Da Rosa AP; Tesh RB
    Am J Trop Med Hyg; 2006 Aug; 75(2):356-62. PubMed ID: 16896148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.
    Kitchener S
    Vaccine; 2004 Jun; 22(17-18):2103-5. PubMed ID: 15149765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal antibody production in two cases of yellow fever vaccine associated neurotropic disease in Argentina.
    Pires-Marczeski FC; Martinez VP; Nemirovsky C; Padula PJ
    J Med Virol; 2011 Dec; 83(12):2208-12. PubMed ID: 22012730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.
    Gaspar LP; Mendes YS; Yamamura AM; Almeida LF; Caride E; Gonçalves RB; Silva JL; Oliveira AC; Galler R; Freire MS
    J Virol Methods; 2008 Jun; 150(1-2):57-62. PubMed ID: 18420285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Yellow fever].
    Wiercińska-Drapało A
    Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models.
    Ma J; Yakass MB; Jansen S; Malengier-Devlies B; Van Looveren D; Sanchez-Felipe L; Vercruysse T; Weynand B; Javarappa MPA; Quaye O; Matthys P; Roskams T; Neyts J; Thibaut HJ; Dallmeier K
    EBioMedicine; 2022 Sep; 83():104240. PubMed ID: 36041265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology.
    Xiao SY; Zhang H; Guzman H; Tesh RB
    J Infect Dis; 2001 May; 183(10):1437-44. PubMed ID: 11319680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic St. Louis encephalitis virus infection in the golden hamster (Mesocricetus auratus).
    Siirin MT; Duan T; Lei H; Guzman H; da Rosa AP; Watts DM; Xiao SY; Tesh RB
    Am J Trop Med Hyg; 2007 Feb; 76(2):299-306. PubMed ID: 17297039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus.
    Doyle MP; Genualdi JR; Bailey AL; Kose N; Gainza C; Rodriguez J; Reeder KM; Nelson CA; Jethva PN; Sutton RE; Bombardi RG; Gross ML; Julander JG; Fremont DH; Diamond MS; Crowe JE
    mBio; 2022 Jun; 13(3):e0051222. PubMed ID: 35420472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model for studying viscerotropic disease caused by yellow fever virus infection.
    Meier KC; Gardner CL; Khoretonenko MV; Klimstra WB; Ryman KD
    PLoS Pathog; 2009 Oct; 5(10):e1000614. PubMed ID: 19816561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies.
    Tesh RB; Guzman H; da Rosa AP; Vasconcelos PF; Dias LB; Bunnell JE; Zhang H; Xiao SY
    J Infect Dis; 2001 May; 183(10):1431-6. PubMed ID: 11319679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(44):989-93. PubMed ID: 12455906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection.
    Kengsakul K; Sathirapongsasuti K; Punyagupta S
    J Med Assoc Thai; 2002 Jan; 85(1):131-4. PubMed ID: 12075714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.